Twenty-one gene recurrence scores in individuals with breast cancer associated with CHEK2 and ATM germline pathogenic variants.

被引:0
|
作者
Shah, Payal Deepak
Brower, Jamie
Cuff, Lauren
Richardville, Robert
Hamilton, Jada G.
Garber, Judy Ellen
Yadav, Siddhartha
Couch, Fergus
Offit, Kenneth
Domchek, Susan M.
Robson, Mark E.
机构
[1] Univ Penn, Philadelphia, PA USA
[2] Univ Penn, Basser Ctr BRCA, Philadelphia, PA USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Mayo Clin, Rochester, MN USA
[6] Univ Penn, Basser Ctr BRCA, Abramson Canc Ctr, Philadelphia, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10585
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Twenty-one gene recurrence scores in individuals with breast cancer associated with PALB2 germline pathogenic variants
    Shah, Payal
    Yadav, Siddhartha
    Brower, Jamie
    Hamilton, Jada
    Simmons, Erica
    Garber, Judy
    Offit, Kenneth
    Robson, Mark
    Couch, Fergus
    Domchek, Susan
    CANCER RESEARCH, 2024, 84 (09)
  • [2] Clinicopathologic features of invasive breast cancer (BC) diagnosed in carriers of germline PALB2, CHEK2 and ATM pathogenic variants.
    Scott, Danika
    Kingham, Kerry
    Hodan, Rachel
    Ma, Cindy
    Mills, Meredith
    Ford, James M.
    Kurian, Allison W.
    Telli, Melinda L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2
    Hinic, Snezana
    Cybulski, Cezary
    Van der Post, Rachel S.
    Vos, Janet R.
    Schuurs-Hoeijmakers, Janneke
    Brugnoletti, Fulvia
    Koene, Saskia
    Vreede, Lilian
    van Zelst-Stams, Wendy A. G.
    Kets, C. Marleen
    Haadsma, Maaike
    Spruijt, Liesbeth
    Wevers, Marijke R.
    Evans, D. Gareth
    Wimmer, Katharina
    Schnaiter, Simon
    Volk, Alexander E.
    Mollring, Anna
    de Putter, Robin
    Soikkonen, Leila
    Kahre, Tiina
    Tooming, Mikk
    de Jong, Mirjam M.
    Vaz, Fatima
    Mensenkamp, Arjen R.
    Genuardi, Maurizio
    Lubinski, Jan
    Ligtenberg, Marjolijn
    Hoogerbrugge, Nicoline
    de Voer, Richarda M.
    GENETICS IN MEDICINE, 2024, 26 (05)
  • [4] Oncotype DX Breast Recurrence Score® analysis in early-stage breast cancer associated with CHEK2, ATM and PALB2 germline pathogenic variants
    Mustafayev, Fatma Akkoc
    Barrera, Angelica Gutierrez
    Liu, Diane
    Arun, Banu
    CANCER RESEARCH, 2024, 84 (09)
  • [5] Increased Prevalence of Germline Pathogenic CHEK2 Variants in Individuals With Pituitary Adenomas
    De Sousa, Sunita M. C.
    McCormack, Ann
    Orsmond, Andreas
    Shen, Angeline
    Yates, Christopher J.
    Clifton-Bligh, Roderick
    Santoreneos, Stephen
    King, James
    Feng, Jinghua
    Toubia, John
    Torpy, David J.
    Scott, Hamish S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (11): : 2720 - 2728
  • [6] Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
    Toss, Angela
    Tenedini, Elena
    Piombino, Claudia
    Venturelli, Marta
    Marchi, Isabella
    Gasparini, Elisa
    Barbieri, Elena
    Razzaboni, Elisabetta
    Domati, Federica
    Caggia, Federica
    Grandi, Giovanni
    Combi, Francesca
    Tazzioli, Giovanni
    Dominici, Massimo
    Tagliafico, Enrico
    Cortesi, Laura
    GENES, 2021, 12 (05)
  • [7] Real-world clinical characteristics and management of breast cancer in patients with germline pathogenic variants in ATM, CHEK2 and PALB2
    Brzeskiewicz, Laura
    Roscow, Breanna
    Beeks, April
    Kunz, Barb
    Ratzel, Sarah
    Slavin, Thomas
    Cummings, Shelly
    Tedesco, Karen
    Reid, Robert
    GENETICS IN MEDICINE, 2022, 24 (03) : S34 - S34
  • [8] Toward a better understanding of the experience of patients with moderate penetrance breast cancer gene pathogenic/likely pathogenic variants: A focus on ATM and CHEK2
    McCormick, Shelley
    Hicks, Stephanie
    Wooters, Mackenzie
    Grant, Carly
    JOURNAL OF GENETIC COUNSELING, 2022, 31 (04) : 956 - 964
  • [9] Germline variant profiling of CHEK2 sequencing variants in breast cancer patients
    McCarthy-Leo, Claire
    Baughan, Scott
    Dlugas, Hunter
    Abraham, Prisca
    Gibbons, Janice
    Baldwin, Carolyn
    Chung, Sarah
    Feldman, Gerald L.
    Dyson, Gregory
    Finley Jr, Russell L.
    Tainsky, Michael A.
    CANCER GENETICS, 2024, 288 : 10 - 19
  • [10] High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
    Irene Rainville
    Shanell Hatcher
    Eric Rosenthal
    Katie Larson
    Ryan Bernhisel
    Stephanie Meek
    Heidi Gorringe
    Erin Mundt
    Susan Manley
    Breast Cancer Research and Treatment, 2020, 180 : 503 - 509